# Labelbox vs Unlearn.AI

Labelbox records 762,803 monthly visits with -22.8% month-over-month growth and Contact for Pricing pricing. Unlearn.AI records 17,107 monthly visits with -32.5% growth and Contact for Pricing pricing.

| Metric | [Labelbox](https://openaitools.app/tool/labelbox) | [Unlearn.AI](https://openaitools.app/tool/unlearn-ai) |
| :--- | :--- | :--- |
| Website URL | https://labelbox.com | https://unlearn.ai |
| Categories | AI Developer Tools, AI API, AI Workflow, AI Productivity Tools | AI Healthcare, AI Research Tool, AI Predictions, AI Models |
| Pricing Model | Contact for Pricing | Contact for Pricing |
| Monthly Visits | 762,803 | 17,107 |
| MoM Growth Rate | -22.8% | -32.5% |
| Primary Market | United States | United States |
| Direct Visits | 370,024 | 7,493 |
| Review Score | 4.4 | 4.4 |
| Saved Count | 0 | 1 |
| Supported Platforms | Website | Website |

## Labelbox

Labelbox occupies an unusual position in the AI stack: it does not primarily sell a chatbot or a generator, it builds the environments and data that models learn from plus the agents that take over recurring engineering and research work. The homepage claim is direct — frontier AI labs train on Labelbox environments and expert data, while engineering and research teams hand their recurring backlog to agents running on Recursion. A recent Series E of more than $100 million signals a heavily funded bet on that thesis.,For enterprises, the newer half of the product is Recursion. Agents are triggered by real signals — a failing build, a PagerDuty alert, a new dependency release, a fresh model checkpoint, or a Monday morning schedule — and then work in the background until the job is done. The examples the company promotes are concrete deliverables rather than summaries: a tested pull request with a preview link, a postmortem draft in Confluence with every event sourced, an ablation table naming the changes that mattered, or a patch for each exposed service after a critical CVE. A grader agent scores each run, and the graded session leaves behind memories, notes and skills that the next session reads before it acts.,The original foundation remains the data business: labeling, annotation, curation and model evaluation supported by expert human reviewers, used for computer vision, NLP, supervised fine-tuning, RLHF and red teaming. In practice the two halves reinforce each other, since the environments that produce high-quality training data are the same environments where agents learn to do real work. Pricing is enterprise-style, routed through sales conversations and shaped by data volume and agent usage, with no public self-serve tier.

**Pricing & Plans:** Contact for pricing. Labelbox does not publish self-serve plans or public rate cards; its pricing route instead directs interested teams to talk to sales, and cost is shaped by data production scope, agent deployment and enterprise requirements. There is no published free tier. Prospective customers should request a quote based on their volumes and use cases.

- **Data labeling and expert annotation:** Structured annotation, curation, model evaluation and human-in-the-loop review across vision, language and generative tasks, used to build the training and eval data behind production models.
- **Autonomous agent sessions:** Recursion agents start on their own from builds, alerts, commits, checkpoints and schedules, then work in the background until the task is finished and reviewable.
- **Domain specialists by function:** Specialist agents cover software engineering, reliability, security, ML research, evals, R&D, product and finance workflows, from flaky test fixes to postmortem drafts and vulnerability patches.
- **Graded outcomes that compound:** Every agent run is scored by a grader, and graded sessions leave memories, notes and skills that the next session reads before acting, so quality compounds over time.
- **Native tool and data integrations:** Agents operate against the tools teams already use, including GitHub, Jira, Linear, Slack, Datadog, PagerDuty, BigQuery, Databricks, Vercel and cloud providers.

**Strengths:** Covers both sides of the problem: training and eval data production plus agents that act on recurring work; Backed by a recent $100M+ Series E and adoption by frontier AI labs, indicating real funding and demand; Agent runs produce concrete deliverables with proof — tests, reruns, ablations — rather than unverified suggestions; Integrates with the toolchain teams already run: GitHub, Jira, Linear, Slack, Datadog, PagerDuty, BigQuery and Databricks

**Limitations:** No self-serve pricing or open signup: everything routes through a sales conversation, which slows down evaluation; The platform assumes real engineering and research infrastructure (GitHub, cloud providers, data warehouses) to deliver value; Positioning has shifted quickly toward autonomous agent sessions, so teams wanting only labeling workflows may find it heavier than needed

[Profile (Markdown)](https://openaitools.app/tool/labelbox.md)

## Unlearn.AI

Unlearn.AI works with biopharma sponsors and clinical research teams at three points in a trial's lifecycle: before the protocol is finalized, while the study is running, and after readout. In design, teams model the patients they expect to enroll and pressure-test sample size, eligibility criteria, endpoints, and comparators before locking the protocol. The company's PROCOVA method — described as EMA-qualified and FDA-supported — applies twin-based covariate adjustment to reduce sample size in randomized controlled trials while holding statistical power, or to increase power without adding patients.

Mid-study, Unlearn supports pre-specified twin-based analyses that tighten interim estimates without enrolling anyone new, and lets teams re-run design scenarios when new evidence — a competitor readout, a fresh publication, or blinded data drifting from assumptions — changes the picture. After a study reads out, digital twins are used to contextualize population, endpoints, and variability, improving sensitivity across endpoints and helping teams re-evaluate historical trial data with regulatory-aligned methods.

Unlearn publishes concrete case outcomes: a 20% sample-size reduction built into a Phase 1/2 design with roughly $2M in savings, a 33% smaller control arm and four-plus months of enrollment time saved in a re-analysis of completed Phase 3 trials from a top-5 global sponsor, and a completed Phase 3 ALS trial re-analyzed to keep full power with 92 fewer participants. The company partners with sponsors including Trace Neuroscience, QurAlis, Acumen Pharmaceuticals, SOLA Biosciences, VectorY Therapeutics, and CHDI Foundation, and states it works with top global pharma companies. Unlearn does not publish list pricing; engagements are scoped through direct contact.

**Pricing & Plans:** Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

- **AI-generated patient digital twins:** Model-based forecasts of each participant's clinical outcomes, generated from baseline data already collected, that act as a virtual comparator or as additional information per enrolled patient.
- **PROCOVA design and analysis method:** A twin-based covariate adjustment approach that Unlearn describes as EMA-qualified and FDA-supported, used to reduce sample size in randomized controlled trials while maintaining power.
- **Trial design scenario modeling:** Build and compare design scenarios — endpoints, eligibility criteria, sample size, assumptions — so governance decisions are made with quantified tradeoffs instead of positions.
- **Interim and readout analysis support:** Pre-specified twin-based analyses added to the statistical analysis plan before unblinding, plus twin-adjusted analysis delivered at interim and at readout.
- **Externally controlled study design:** Design single-arm and externally controlled studies where randomization is not an option, selecting eligibility criteria that give open-label studies the best chance of a clear readout.

**Strengths:** Digital twins are generated from data already collected, so no extra patients are required to gain information; Publicly reported, quantified outcomes — sample-size reductions, cost savings, and enrollment time saved — rather than only qualitative claims; Covers the whole trial lifecycle: design, interim, and readout, not just one decision point; Named collaborations with biotech and pharma sponsors, plus regulatory-aligned methodology

**Limitations:** Pricing is not published, so budgeting requires a direct sales conversation; The value proposition depends on regulatory acceptance of twin-based methods, which varies by agency and indication; Best suited to sponsors with existing clinical data and statistical teams; not a self-serve tool; Public metrics come from specific studies and may not transfer directly to other indications

[Profile (Markdown)](https://openaitools.app/tool/unlearn-ai.md)

## Frequently Asked Questions

### How do Labelbox and Unlearn.AI compare in monthly traffic?

Labelbox has 762,803 monthly visits, while Unlearn.AI has 17,107. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Labelbox has a month-over-month growth rate of -22.8%; Unlearn.AI has -32.5%.

### How does pricing compare?

Labelbox: Contact for Pricing. Contact for pricing. Labelbox does not publish self-serve plans or public rate cards; its pricing route instead directs interested teams to talk to sales, and cost is shaped by data production scope, agent deployment and enterprise requirements. There is no published free tier. Prospective customers should request a quote based on their volumes and use cases. Unlearn.AI: Contact for Pricing. Enterprise, contact-for-pricing model. Unlearn does not publish standard subscription tiers; engagements are scoped per study or program after a conversation with the team.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Roboflow](https://openaitools.app/tool/roboflow) | 1,431,204 | +6.6% | Freemium, Contact for Pricing | Streamlines end-to-end computer vision workflows from annotation to model deployment, but lacks Labelbox's general enterprise agent orchestration. | [.md](https://openaitools.app/tool/roboflow.md) |
| 2 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 3 | [Appen](https://openaitools.app/tool/appen-com) | 665,840 | +0.2% | Contact for Pricing | Relies heavily on managed human-in-the-loop workforce services for data validation, offering less self-serve technical tooling than Labelbox. | [.md](https://openaitools.app/tool/appen-com.md) |
| 4 | [Scale](https://openaitools.app/tool/scale) | 616,915 | +12.5% | Contact for Pricing | Delivers enterprise-grade labeling and model evaluation at massive scale, but often requires higher enterprise budgets than Labelbox. | [.md](https://openaitools.app/tool/scale.md) |
| 5 | [SuperAnnotate](https://openaitools.app/tool/super-annotate) | 386,034 | +37.4% | Free Trial, Contact for Pricing | Offers robust multimodal annotation and workflow automation, featuring slightly more intuitive data curation pipelines for computer vision teams. | [.md](https://openaitools.app/tool/super-annotate.md) |
| 6 | [Upheal](https://openaitools.app/tool/upheal-io) | 347,782 | -2.1% | Freemium, Free Trial, Contact for Pricing | AI therapy notes and an AI-native EHR built for mental health professionals. | [.md](https://openaitools.app/tool/upheal-io.md) |
| 7 | [Weights & Biases (CoreWeave Forge)](https://openaitools.app/tool/prompts) | 315,624 | -80.2% | Freemium, Contact for Pricing, Free | Track, evaluate, and ship AI models and agents in one connected environment. | [.md](https://openaitools.app/tool/prompts.md) |
| 8 | [Encord](https://openaitools.app/tool/encord-com) | 244,204 | +9.4% | Contact for Pricing | Specializes in advanced computer vision and physical AI data pipelines, though with a narrower focus than general text-and-image labeling. | [.md](https://openaitools.app/tool/encord-com.md) |
| 9 | [Label Studio](https://openaitools.app/tool/label-studio) | 137,199 | -16.1% | Contact for Pricing, Free | Provides a flexible open-source alternative for custom data labeling, but requires self-hosting and manual infrastructure maintenance. | [.md](https://openaitools.app/tool/label-studio.md) |
| 10 | [Confident AI](https://openaitools.app/tool/confident-ai) | 83,400 | -3.3% | Freemium, Paid, Contact for Pricing | Focuses strictly on LLM evaluation, testing, and observability rather than raw data annotation and training dataset curation. | [.md](https://openaitools.app/tool/confident-ai.md) |

---
Source: https://openaitools.app/compare/labelbox-vs-unlearn-ai

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
